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Chronic rhinosinusitis’ pathogenesis is not completely 
established and there are some explanations for this 
disease, such as osteitis, superantigens, fungal-mediated 
hypersensitivity and, more recently, biofilms. There are no 
reports in Portuguese about biofilms in chronic rhinosinusitis. 
Aim: To reproduce a method for visualization of biofilms in 
patients with chronic rhinosinusitis and nasal polyps. Patients 
and Methods: Samples of ethmoid bulla of nine patients with 
chronic rhinosinusitis with nasal polyps without response to 
clinical treatment who underwent surgery were analyzed with 
scanning electron microscopy to evidence bacterial biofilms. 
Study design: A contemporary cross-sectional cohort study 
Results: In 55.56% (5/9) of the patients we observed biofilms 
by seeing three-dimensional structures, spherical structures 
surrounded by an amorphous matrix and water-channels. 
Conclusion: We reproduced a method for visualization 
of bacterial biofilms by scanning electron microscopy and 
evidenced its presence in chronic rhinosinusitis with nasal 
polyps. 
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INTRODUCTION
Chronic rhinosinusitis is one of the most common 
complaints in North-American medical visits, and one of 
the main reasons for antibiotic prescriptions and leave of 
work. About 135 in 1,000 persons - 31 million people - are 
affected yearly in the US; the total yearly cost is estimated 
at 6 billion US dollars.1-3
A classification of rhinosinusitis according to time 
separates them into acute cases (lasting up to 12 weeks) 
and chronic (lasting over 12 weeks). Chronic rhinosinusitis 
includes a group with no nasal polyps and another with 
nasal polyps.4-6 Histopathological findings are difference 
in chronic rhinosinusitis with and without nasal polyps; 
the former contains an eosinophil infiltrate, while the 
latter has a neutrophil infiltrate, reflecting a different pa-
thophysiology.4 Voegels and Padua have also suggested 
other differences in the inflammatory response, such as 
a significant decrease in the amount of interleukins in 
chronic rhinosinusitis with nasal polyps that progressed 
to a good postoperative outcome.7
Several theories have been raised to explain the 
pathophysiology of chronic rhinosinusitis. It is currently 
thought that chronic rhinosinusitis is an immunological 
inflammatory disease caused simultaneously or singly by 
several factors, such as: immune conditions, intrinsic upper 
airway factors, Staphylococcus aureus superantigens, fun-
gal colonization that induces and maintains eosinophilic 
inflammation, metabolic disorders such as aspirin hyper-
sensitivity, and persistent insult by biofilms and/or osteitis.4
Biofilm consists of gathered microorganism cells 
anchored irreversibly to a live or inert surface, encased 
in a self-produced extracellular polymer matrix consisting 
mostly of polysaccharides, which comprises over 90% of 
the biofilm mass.8-11 This conditions makes biofilms highly 
resistant to changes in pH, temperature, and antibiotic ac-
tion, which possibly explains persistent chronic infections 
that resist clinical therapy, such as chronic rhinosinusitis 
with nasal polyps.8-11
Post (2001) carried out the first study to assess the 
presence of biofilms in otorhinolaryngology, in which 
this author applied scanning electron microscopy (SEM) 
to identify biofilms in ventilation tubes, associating these 
structures with otitis media in an animal model.12 Biofilms 
have also been demonstrated in cholesteatomas, chronic 
tonsillitis, adenoids of patients with chronic sinusitis, 
and infections associated with biomaterials such as voice 
prostheses.13-15
Perloff and Palmer conducted several studies that 
confirmed the presence of biofilms on the mucosa of 
patients with chronic rhinosinusitis;16-18 these biofilms 
could explain why such patients improved after a course 
of antibiotics and relapsed after medication was ceased.19 
Other studies applying transmission electron microscopy 
and confocal laser microscopy with fluorescence in situ 
hybridization have demonstrated the presence of bacteria 
inside biofilms.19-21
No papers have been published in Portuguese about 
bacterial biofilms in chronic rhinosinusitis. The purpose of 
this study was to reproduce a method for demonstrating 
bacterial biofilms in chronic rhinosinusitis; this is one of 
the aims of a wider set of studies being conducted at the 
Rhinology Division of the Otorhinolaryngology Discipline 
at our institution. Concluding this step was essential to 
apply this tool for further studies.
AIM
The purpose of this study was to identify bacterial 
biofilms on the mucosa of patients with chronic rhinosi-
nusitis and nasal polyps.
PATIENTS AND METHODS
Patients
This was a contemporary cohort cross-sectional 
study carried out from February to May 2008. The report 
comprises the first nine chronic rhinosinusitis patients with 
nasal polyps that did not respond to medical therapy, and 
that are part of a prospective cohort study that is being 
undertaken at a tertiary level hospital. All patients agreed 
to sign the free informed consent form that was authorized 
by the Institutional Review Board of the hospital (number 
0669/07).
Chronic rhinosinusitis with polyps was defined 
based on clinical and endoscopic criteria, as follows: a 
clinical history containing two or more of the following 
symptoms lasting over 12 weeks, one of the symptoms 
being any of the first two of nasal block or congestion, 
anterior nasal discharge or pos-nasal drip, facial pain or 
sense of pressure, and decreased or absent olfaction;5 
endoscopy revealing bilateral nasal polyps.5,6
Absence of response to medical therapy was defined 
as a time period over three months with no improvement 
after using topical nasal corticosteroids with or without 
oral antibiotics, leukotriene antagonists and/or inhibitors, 
isotonic nasal saline solutions, and/or systemic corticos-
teroids. Patients were aged 18 years or above.
Patients with an optical microscopy histological 
analysis of nasal polyps showing predominantly non-eo-
sinophilic cell infiltrates, with secondary causes of chronic 
rhinosinusitis (fungus ball, invasive fungal disease, granu-
lomatous diseases, vasculitis, mucoceles alone, nasosinusal 
malignant and benign tumors, congenital anomalies (such 
as primary ciliary dyskinesia, cystic fibrosis, craniofacial 
congenital anomalies,  oroantral fistulae, and primary and 
secondary immune deficiencies) were excluded.
We collected tissue samples of the ethmoidal bulla 
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of these patients when carrying out functional endoscopic 
sinus surgery (FESS) from February to April 2008.
Method
Tissue specimens measuring about 1.0 x 1.0 cm 
were harvested during surgery done by one of the medical 
residents of our unit, and fixed for 2 hours in 2% glutaral-
dehyde and buffered with 0.15 M phosphate (pH 7.2) at 
room temperature. Each specimen was washed three times 
in a lavage solution containing NaCl (1.2 g), sucrose (14.6 
g), and distilled water (200 ml), and post-fixed for 1 hour 
in 1% OsO4. Samples were then dehydrated in a series of 
increasing concentrations of ethyl alcohol (70% to 100%), 
critical point dried in CO
2
, and placed on mounts for SEM. 
Platinum coating was done for observation with a Quanta 
600 FEG scanning electron microscope; the acceleration 
voltage was 10kV. Photomicrographs were captured in 
TIFF format at 1,000 to 12,000 magnifications. An expe-
rienced pathologist in ultra-structures (P.H.N.S) searched 
for images of bacterial biofilms in photomicrographs by 
looking for tree-dimensional structures containing sphe-
rical structures enveloped by an amorphous matrix and 
the water channels connecting these spherical structures. 
Microbiological cultures were not performed.
RESULTS
SEM was carried out to analyze the samples of 
nine patients; biofilms were found in 5 of the 9 patients 
(55.56%), based on published criteria.9,10,12,13,16,17,19-20,22 The 
sample comprised seven men and two women with a 
mean age of 37 years ±11 years (22-60 years). The mean 
Lund-Mackay staging was 14.4 ±1.2 (12-16), and the mean 
Meltzer classification was 2.8 ±0.4(2-3) to the right and 
3±0.5(3-4) to the left (Table 1). The three-dimensional 
structure, spherical structures enveloped by an amorphous 
matrix, and water channels connecting these spherical 
structures were visualized (Figs. 1-5). Cilia were demons-
trated in one case only; the epithelium of the remaining 
patients was devoid of cilia, showing squamous metaplasia 
and absence of goblet cells (Fig. 6).
Table 1. List of patients with data on the presence of biofilms, sex, 
age, tomographic (Lund-Mackay) and endoscopic (Meltzer) classifi-
cations.
Biofilm Sex Age Lund-Mackay Meltzer D/E
+ M 26 15 3/4 
+ M 21 14 3/3
- M 41 12 3/3
+ M 60 15 3/4
- F 36 13 3/3
- M 41 16 3/3
+ M 35 15 2/3
- M 36 15 3/3
+ F 37 15 2/4
+ Present, - Absent, M - Male, F - Female, D - Right nasal fossa, E - 
Left nasal fossa
Figure 1a. Bacterial biofilm (12.000x)
Figure 1b. Bacterial biofilm - illustration
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DISCUSSION
Patients with chronic rhinosinusitis presented 
complaints that persisted in time, often regressing with 
antibiotics and relapsing after their cessation. Biofilms 
may explain why antibiotics are unable to eliminate this 
chronically established bacterial population. Bacteria in 
biofilms are enveloped by a glycopolysaccharide matrix 
and may grow coordinately after a certain cell density is 
reached, by inducing several signaling molecular, which 
is known as quorum sensing.19 This is a complex group of 
bacteria anchored to a surface, clustered in a tower and 
mushroom-shaped syncytium.17
Biofilms are less susceptible to antibiotics, grow 
slowly and generate planktonic bacteria intermittently 
(which are more susceptible to host defenses and antibio-
tics). These free-living bacteria appear to be responsible 
for the symptoms of infection.19
The importance given to human diseases is recent 
also in our specialty.13 Although in the past, microbiologists 
have looked at bacteria in their planktonic form, medical 
recalcitrance to antibiotics has increased interest in the 
Figure 3. Bacterial biofilm (magnified 12.000x)
Figure 4. Bacterial biofilm (12.000x)
Figure 5. Bacterial biofilm (12.000x)
Figure 2. Bacterial biofilm (magnified 5.000x)
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behavior of bacteria when they colonize surfaces and 
produce biofilms.22 Recent papers of the North-American 
Centers for Disease Control and Prevention (CDC) have 
estimated that at least 65% of all chronic bacterial infec-
tions in humans involve biofilms.8,23 Relevant organisms in 
otorhinolaryngological diseases have been shown to form 
biofilms, such as Pseudomonas aeruginosa, Haemophilus 
influenzae, Streptococcus pneumoniae and Staphylococ-
cus aureus.13
Besides chronic rhinosinusitis, bacterial biofilms 
have been demonstrated in other disease such as suppu-
rative otitis media, prostatitis, osteomyelitis, bacterial endo-
carditis, cystic fibrosis, pneumonia, and severe tonsillitis.13
Difficulties in demonstrating biofilms in cultures of 
patients with chronic rhinosinusitis may be explained by 
the presence of a gene - in P. aeruginosa it is the pvrR 
gene - that becomes active in response to specific environ-
mental conditions; in common culture media, the bacteria 
does not form biofilms and is susceptible to antibiotics.24 
Other studies have shown that bacterial culture findings 
correlate poorly with the presence of biofilms and the 
types of bacteria within.21
Biofilms demonstrated by SEM in the present study 
was confirmed with images that are similar to those publi-
shed in previous studies.17,18 Biofilms were identified in five 
(55.56%) of nine subjects in this pilot study. This highlights 
the importance of reevaluating the current treatments of 
chronic rhinosinusitis, because antibiotics have already 
been shown to be ineffective against biofilms. We point 
out that only mucosa of the ethmoidal bulla was harves-
ted; possibly samples from other facial sinuses might have 
yielded different results. Surgical ventilation, mechanical 
disruption of biofilms and detergents may become thera-
peutic choices. Surgery may be effective because it causes 
the infected cavity to be ventilated, thus increasing the 
oxygen tension in the ambience around biofilms.17 Biofilms 
are not always detected, even in studies of guinea pigs 
with chronic rhinosinusitis. In one of these studies, the 
number of guinea pigs with biofilms detected by confocal 
microscopy was smaller than those detected with SEM (48% 
x 86%). It is thought that confocal microscopy is more 
precise than SEM because it specifically detects bacteria; 
in these papers, however, markers for other agents present 
in biofilms, such as fungi, were not used.25
A possible limitation of SEM is that preparation of 
the specimen involves dehydration and may cause protein 
cross-links that give rise to artifacts similar to biofilms. 
Dehydration reduces the size of biofilms and minimally 
distorts its architecture; it remains, however, easily recog-
nizable, as demonstrated by comparison with cryofixation. 
It is possible that biofilms may be extracted during prepa-
ration or that they may not be seen by being too small.20
Recent studies have correlated the presence of 
biofilms with a worse prognosis in patients with chronic 
rhinosinusitis.20,26,27 Other studies have sought alternative 
methods for removing biofilms, such as using children’s 
shampoo.28 Surgical failure may be attributed to biofilms 
when these are not eradicated. Biofilm persistence in the 
folds of edematous and chronically inflamed mucosa in 
which cilia are absent may lead to rapid reinfection.29
Other factors are also relevant in chronic rhinosi-
nusitis with nasal polyps, since polyps were not seen in 
nearly half of such patients in this study. The bacterial 
superantigen, osteitis, and fungus-mediated hypersensi-
tivity also contribute significantly to the pathogenesis of 
chronic rhinosinusitis; these factors were not investigated 
in this pilot study, although they modify the progression 
of chronic rhinosinusitis with polyps.4,30 It is not known 
how much each of these factors contributes to the genesis 
or maintenance of chronic rhinosinusitis. Similarly, the 
presence of biofilms in tissue samples of patients with 
chronic rhinosinusitis and polyps is a fact; it remains 
unclear whether biofilms in such cases are the cause or 
consequence of persistent infection.
In this study we reproduced a biofilm detection 
method, which may provide more tools for studies seeking 
solutions for chronic rhinosinusitis. This is the first paper 
on biofilms published in Portuguese. The progression of 
patients with chronic rhinosinusitis and polyps is consistent 
with the current knowledge about biofilms, where there 
are relapses after using antibiotics and improvement after 
the biofilm mass is removed; additional studies, however, 
are needed to define whether biofilms are the cause or 
consequence in chronic rhinosinusitis with polyps.
Figure 6. Non-ciliated cylindrical epithelium next to the squamous 
metaplasia
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CONCLUSION
This study evidences the presence of biofilms in 
chronic rhinosinusitis patients with nasal polyps, showing 
their 3-dimensional structure, spherical structures surroun-
ded by an amorphous matrix and its water channels.
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